Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Not applicableActive Not RecruitingNCT03531658
What this trial is testing

Singapore PREconception Study of Long-Term Maternal and Child Outcomes

Who this might be right for
Metabolic DiseaseNeurological and Mental Health ConditionsGenetics Predisposition+4 more
KK Women's and Children's Hospital 1,054
Testing effectiveness (Phase 2)Ended earlyNCT00089778
What this trial is testing

Vaccine Treatment of Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)UnknownNCT02066038
What this trial is testing

Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Who this might be right for
Lung, Carcinoma
Sun Yat-sen University 60
Large-scale testing (Phase 3)Study completedNCT03615326
What this trial is testing

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

Who this might be right for
Gastric NeoplasmsGastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLC 738
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06545695
What this trial is testing

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

Who this might be right for
Epidermolytic IchthyosisPalmoplantar KeratodermaPachyonychia Congenita
Northwestern University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06750185
What this trial is testing

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 248
Post-approval studies (Phase 4)UnknownNCT01845090
What this trial is testing

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23

Who this might be right for
Other Nonspecific Abnormal Serum Enzyme Levels
Camillians Saint Mary's Hospital Luodong 30
Testing effectiveness (Phase 2)Ended earlyNCT01702558
What this trial is testing

A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)

Who this might be right for
Breast CancerGastric Cancer
Hoffmann-La Roche 182
Early research (Phase 1)UnknownNCT01163825
What this trial is testing

Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients

Who this might be right for
Alzheimer's Disease
NsGene A/S 6
Not applicableEnded earlyNCT00919360
What this trial is testing

Gene Expression In Pregnancies Complicated by Preeclampsia

Who this might be right for
Preeclampsia
University of Rochester 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT03363217
What this trial is testing

Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

Who this might be right for
Low-grade GliomaPlexiform NeurofibromaCentral Nervous System Glioma
St. Justine's Hospital 114
Not applicableEnded earlyNCT01994174
What this trial is testing

Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics

Who this might be right for
Macular Disease
University of Nebraska 13
Early research (Phase 1)Study completedNCT00658658
What this trial is testing

Panitumumab in Children With Solid Tumors

Who this might be right for
Solid Tumors
Amgen 31
Early research (Phase 1)Study completedNCT02503774
What this trial is testing

MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.

Who this might be right for
Solid Tumors
MedImmune LLC 192
Early research (Phase 1)Looking for participantsNCT07660055
What this trial is testing

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Who this might be right for
Breast CancerNon-small Cell Lung Cancer (NSCLC)Gastric/Gastroesophageal Junction (GEJ) Cancer+1 more
Novartis Pharmaceuticals 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT06194448
What this trial is testing

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

Who this might be right for
Lung Cancer
AstraZeneca 76
Testing effectiveness (Phase 2)Looking for participantsNCT07154290
What this trial is testing

Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung CancerAdvanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer+1 more
Regeneron Pharmaceuticals 300
Large-scale testing (Phase 3)UnknownNCT05382390
What this trial is testing

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

Who this might be right for
Acute Myeloid Leukemia
Huihan Wang 130
Testing effectiveness (Phase 2)Looking for participantsNCT06510582
What this trial is testing

Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection

Who this might be right for
Chronic Subdural Hematoma
The Cooper Health System 140
Next Page